Lixte Biotechnology to Present Key Advantages of Novel Cancer Drug Candidate LB-100 at the ...

Retrieved on: 2021-05-04 20:26:15

Tags for this article:

Click the tags to see associated articles and topics

Lixte Biotechnology to Present Key Advantages of Novel Cancer Drug Candidate LB-100 at the .... View article details on hiswai:

Excerpt

EAST SETAUKET, NY, May 04, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery ...

Article found on: www.globenewswire.com